Prevalence of Replication of Human Herpes Virus 6 (HHV6) in Blood and Skin During Exanthemia, in Patients With Hemopathy. Is There a Correlation With the Etiology of the Exanthema? (REPLIPO)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03102905
Recruitment Status : Unknown
Verified March 2017 by Centre Hospitalier Universitaire, Amiens. Recruitment status was: Recruiting
To look for the replication of HHV6 by PCR in the skin, in these patients with haemopathies presenting an exanthema. This will make it possible to evaluate the prevalence of the positivity of this PCR in the skin. Then the investigator can investigate whether there is an association between the positivity of HHV6 PCR in the blood and / or skin and the viral etiology of the exanthema. If this association exists, it will make it possible to improve the diagnosis in the context of the exanthema and thus to improve the therapeutic management of these patients.
Condition or disease
Other: Measurement of the prevalence of the positivity of cutaneous HHV6 quantitative PCR in the cohort studied.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
Child, Adult, Older Adult
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Any patient hospitalized in the Clinical Hematology and Cellular Therapy department of the CHU Amiens-Picardie between 01/01/2011 and 31/01/2016
Supported for any type of hemopathy.
Allograft, autografted or ungrafted haematopoietic stem cells
Having presented an exanthema during hospitalization, for which a cutaneous biopsy had been performed
Having had a blood test of the HHV6 virus by PCR at least within the previous 40 days or following the rash.
Age greater than or equal to 18 years
Patient informed of the protocol by post, not having refused within one month of sending the said courier.
Patient who refused the search.
Patient whose HHV6 PCR in the blood was carried out at a distance of more than 40 days from the skin biopsy.